Product review of DrugPatentWatch (value - help & training; competitors; development; pricing)
Jinfo Article
24th January 2018
By Scott Vine
Abstract
In the final part of our product review of DrugPatentWatch, a database which provides actionable business intelligence on small-molecule drugs, we look at the help and training that's available to users along with detailed pricing information. We also highlight the value of the product and how it can be used as a business analysis tool rather than just be used for patent searching, and where it sits against competitor or complementary products such as Cortellis, Clarivate and AdisInsight.
Note: Full review (PDF) at /go/sub/report/2934
Content Access
Does your organisation have a Jinfo Subscription?
Access to Jinfo Content and Community is available through a Jinfo Subscription.
"Yes"
Please sign in to MyJinfo here so that we can check your access to this item:
Or sign in via email:
Enter your email and we'll send you a magic link to sign you in automatically.
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: Product review of DrugPatentWatch (value - help & training; competitors; development; pricing)
- Link to this page
- View printable version
Related articles:
- Product review of DrugPatentWatch (technology - search & user interface; outputs & alerts; administration)
Tuesday, 23rd January 2018 - Product review of DrugPatentWatch (sources - content & coverage)
Monday, 22nd January 2018 - Product review of DrugPatentWatch (key advantages; introduction; contact details)
Friday, 19th January 2018
Related reports:
- Product review of DrugPatentWatch
Friday, 19th January 2018 - Market landscape - patent products
Thursday, 20th July 2017